Harm Reduction: Community Perspectives Summary Report

The Reagan-Udall Foundation for the FDA, in partnership with operating divisions within the Department of Health and Human Services, convened two roundtable meetings, one to understand the perspectives of the harm reduction community about using fentanyl drug checking and screening as harm reduction and clinical strategies, and another to understand clinicians and researchers perspectives. This report summarizes the discussion from the roundtable meeting on community perspectives.